We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
(-4.3%)
Cap. Flow
-$587M
Cap. Flow
% of AUM
-4.35%
Top 10 Holdings %
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$30.1M |
| 2 |
Energy Transfer Partners
ET
|
+$24.7M |
| 3 |
Franklin FTSE Japan ETF
FLJP
|
+$11.8M |
| 4 |
Wells Fargo
WFC
|
+$9.66M |
| 5 |
Alkermes
ALKS
|
+$8.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$49.8M |
| 2 |
Enterprise Products Partners
EPD
|
+$49.1M |
| 3 |
Western Midstream Partners
WES
|
+$44.8M |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$42.5M |
| 5 |
EQM
EQM Midstream Partners, LP
EQM
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.41% |
| 2 | Financials | 7.05% |
| 3 | Healthcare | 3.6% |
| 4 | Consumer Discretionary | 3.1% |
| 5 | Technology | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Vanda Pharmaceuticals
VNDA
$312M
| $286K | ﹤0.01% |
20,284
-1,070
| -5% | -$17K |
|
|
HSII
852
DELISTED
Heidrick & Struggles
HSII
| $282K | ﹤0.01% |
9,416
-496
| -5% | -$17.4K |
|
853
American Superconductor
AMSC
$1.48B
| $279K | ﹤0.01% |
30,063
+16,762
| +126% | +$178K |
|
854
PetMed Express
PETS
$42.5M
| $279K | ﹤0.01% |
17,828
-940
| -5% | -$18.5K |
|
|
CNR
855
Core Natural Resources Inc
CNR
$4.19B
| $276K | ﹤0.01% |
10,388
-559
| -5% | -$16.7K |
|
|
SWN
856
DELISTED
Southwestern Energy Company
SWN
| $275K | ﹤0.01% |
86,994
-4,588
| -5% | -$17.8K |
|
857
Cousins Properties
CUZ
$5.29B
| $271K | ﹤0.01% |
+7,500
| New | +$282K |
|
858
Gray Television
GTN
$407M
| $271K | ﹤0.01% |
16,513
-871
| -5% | -$17.3K |
|
|
DNR
859
DELISTED
Denbury Resources, Inc.
DNR
| $270K | ﹤0.01% |
217,487
-11,468
| -5% | -$20.8K |
|
|
GAP
860
The Gap Inc
GAP
$6.84B
| $265K | ﹤0.01% |
14,740
-3,598
| -20% | -$80.7K |
|
861
Compass Diversified
CODI
$755M
| $264K | ﹤0.01% |
13,800
-160,400
| -92% | -$2.74M |
|
862
New Mountain Finance
NMFC
$646M
| $258K | ﹤0.01% |
+18,500
| New | +$259K |
|
|
KDNY
863
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $258K | ﹤0.01% |
33,505
-4,853
| -13% | -$73.9K |
|
|
EXK
864
Endeavour Silver
EXK
$2.32B
| $257K | ﹤0.01% |
125,558
-90,629
| -42% | -$185K |
|
865
Future Fuel
FF
$204M
| $253K | ﹤0.01% |
21,674
-1,143
| -5% | -$14.2K |
|
866
Covenant Logistics
CVLG
$1.18B
| $248K | ﹤0.01% |
33,738
-1,780
| -5% | -$15.6K |
|
|
ZAGG
867
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $246K | ﹤0.01% |
35,345
-1,863
| -5% | -$14K |
|
|
GPOR
868
DELISTED
Gulfport Energy Corp.
GPOR
| $243K | ﹤0.01% |
49,582
-2,615
| -5% | -$16.7K |
|
869
Chemours
CC
$2.59B
| $238K | ﹤0.01% |
9,918
-3,177
| -24% | -$93.6K |
|
870
Brookfield Infrastructure Partners
BIP
$18.8B
| $236K | ﹤0.01% |
9,238
-72,744
| -89% | -$1.81M |
|
|
BPT
871
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $226K | ﹤0.01% |
14,615
-771
| -5% | -$15.2K |
|
|
ROCC
872
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $206K | ﹤0.01% |
6,718
-355
| -5% | -$13.2K |
|
|
BPMP
873
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $199K | ﹤0.01% |
12,867
+324
| +3% | +$4.81K |
|
874
Savara
SVRA
$1.13B
| $178K | ﹤0.01% |
74,996
-9,854
| -12% | -$87.5K |
|
875
Mammoth Energy Services
TUSK
$132M
| $123K | ﹤0.01% |
17,878
-943
| -5% | -$12K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.
- ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
- ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
- ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
- ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
- ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
- ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
- ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.
Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.